BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28791678)

  • 21. [Predictive value of Glasgow prognostic score in patients with colorectal cancer undergoing laparoscopic radical resection].
    Cao X; Yu T; Zhao G; Xiao G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1133-1138. PubMed ID: 27781250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
    Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G
    Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum level of endothelial cell-specific molecule-1 and prognosis of colorectal cancer.
    Jiang H; Fu XG; Chen YT
    Genet Mol Res; 2015 May; 14(2):5519-26. PubMed ID: 26125749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of circulating endothelial cells in metastatic colorectal cancer.
    Rahbari NN; Schölch S; Bork U; Kahlert C; Schneider M; Rahbari M; Büchler MW; Weitz J; Reissfelder C
    Oncotarget; 2017 Jun; 8(23):37491-37501. PubMed ID: 28415583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival.
    Nicolini A; Ferrari P; Duffy MJ; Antonelli A; Rossi G; Metelli MR; Fulceri F; Anselmi L; Conte M; Berti P; Miccoli P
    Arch Surg; 2010 Dec; 145(12):1177-83. PubMed ID: 21173292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of IRF-2 expression in colorectal cancer.
    Mei Z; Wang G; Liang Z; Cui A; Xu A; Liu Y; Liu C; Yang Y; Cui L
    Oncotarget; 2017 Jun; 8(24):38969-38977. PubMed ID: 28465494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
    Yang XQ; Chen C; Wang FB; Peng CW; Li Y
    Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
    Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer.
    Olsen RS; Nijm J; Andersson RE; Dimberg J; Wågsäter D
    World J Gastroenterol; 2017 Sep; 23(34):6212-6219. PubMed ID: 28974887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative alkaline phosphatase elevation was associated with poor survival in colorectal cancer patients.
    Hung HY; Chen JS; Chien-YuhYeh ; Tang R; Hsieh PS; Wen-SyTasi ; You YT; You JF; Chiang JM
    Int J Colorectal Dis; 2017 Dec; 32(12):1775-1778. PubMed ID: 29030683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Mortalin correlates with poor outcome in hepatocellular carcinoma.
    Cheng W; Zhang B; Zikeliyar M; Wang J; Jian H; Wu K; Zhang Y; Ding J
    Ann Diagn Pathol; 2019 Oct; 42():59-63. PubMed ID: 31310900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating Heat Shock Protein 70 Is a Novel Biomarker for Early Diagnosis of Lung Cancer.
    Tang T; Yang C; Brown HE; Huang J
    Dis Markers; 2018; 2018():6184162. PubMed ID: 30245753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortalin is a distinct bio-marker and prognostic factor in serous ovarian carcinoma.
    Xu M; Jin T; Chen L; Zhang X; Zhu G; Wang Q; Lin Z
    Gene; 2019 May; 696():63-71. PubMed ID: 30776464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
    Cui R; Shi XY
    Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic role of methylated free circulating DNA in colorectal cancer.
    Philipp AB; Stieber P; Nagel D; Neumann J; Spelsberg F; Jung A; Lamerz R; Herbst A; Kolligs FT
    Int J Cancer; 2012 Nov; 131(10):2308-19. PubMed ID: 22362391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.